This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.
Exscientia PLC is an artificial intelligence-driven biotechnology company whose core business model involves the discovery and development of pharmaceutical drugs using AI. A central component of this preclinical research and development process is animal testing. The company conducts in vivo studies to validate drug candidates, a standard practice in the industry that inherently involves the commercial use of laboratory animals.
While Exscientia states its AI platform is designed to improve the efficiency of drug discovery, the company's operations remain reliant on animal experimentation as part of the regulatory pathway for bringing new drugs to market. This business activity places the company within the broader pharmaceutical research sector, which is a primary commercial driver of animal testing at scale. The specific nature and volume of Exscientia's animal testing operations are not detailed in public disclosures, but its business model is fundamentally predicated on this use of animals.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.